Regulation of C2C12 myogenic terminal differentiation by MKK3/p38α-pathway

American Journal of Physiology - Cell Physiology

Volumn 284, Issue 3 53-3, 2003, Pages

  Cabane, Candice ^a   Englaro, Walter ^a   Yeow, Karen ^a   Ragno, Michel ^a   Dérijard, Benoît ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Cytoskeleton; Mitogen activated protein kinase; Mitogen activated protein kinase kinase 3 dominant negative mutant; Muscle; Signaling

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA GALACTOSIDASE; MITOGEN ACTIVATED PROTEIN KINASE; MYOD PROTEIN; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEIN P21; PROTEIN P27; TROPONIN T;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALIA;

EID: 0037370695     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00078.2002     Document Type: Article

References (37)

1. Akkila WM, Chambers RL, Ornatsky OI, and McDermott JC. Molecular cloning of up-regulated cytoskeletal genes from regenerating skeletal muscle: potential role of myocyte enhancer factor 2 proteins in the activation of muscle-regeneration-associated genes. Biochem J 325: 87-93, 1997.
2. Andres V and Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132: 657-666, 1996.
3. Buckingham M and Tajbakhsh S. Expression of myogenic factors in the mouse: myf-5, the first member of the MyoD gene family to be transcribed during skeletal myogenesis. C R Acad Sci III 316: 1032-1046, 1993.
4. Chun YK, Kim J, Kwon S, Choi SH, Hong F, Moon K, Kim JM, Choi SL, Kim BS, Ha J, and Kim SS. Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 276: 502-507, 2000.
5. Cuenda A and Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 274: 4341-4346, 1999.
6. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, and Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995.
7. Cusella-De Angelis MG, Lyons G, Sonnino C, De Angelis L, Vivarelli E, Farmer K, Wright WE, Molinaro M, Bouche M, and Buckingham M. MyoD, myogenin independent differentiation of primordial myoblasts in mouse somites. J Cell Biol 116: 1243-1255, 1992.
8. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
9. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, and Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994.
10. Dérijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, and Davis RJ. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267: 682-685, 1995.
11. Franklin DS and Xiong Y. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell 7: 1587-1599, 1996.
12. Fujio Y, Guo K, Mano T, Mitsuuchi Y, Testa JR, and Walsh K. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol 19: 5073-5082, 1999.
13. Galbiati F, Volonte D, Engelman JA, Scherer PE, and Lisanti MP. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 274: 30315-30321, 1999.
14. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, and Wewer UM. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 273: 157-166, 1998.
15. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, and Davis RJ. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770, 1996.
16. Han J, Jiang Y, Li Z, Kravchenko VV, and Ulevitch RJ. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386: 296-299, 1997.
17. Han J, Lee JD, Bibbs L, and Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811, 1994.
18. Herrmann H and Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 12: 79-90, 2000.
19. Hibi M, Lin A, Smeal T, Minden A, and Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135-2148, 1993.
20. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene 18: 6087-6093, 1999.
21. Keesler GA, Bray J, Hunt J, Johnson DA, Gleason T, Yao Z, Wang SW, Parker C, Yamane H, Cole C, and Lichenstein HS. Purification and activation of recombinant p38 isoforms alpha, beta, gamma, and delta. Protein Expr Purif 14: 221-228, 1998.
22. Kelly R, Alonso S, Tajbakhsh S, Cossu G, and Buckingham M. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J Cell Biol 129: 383-396, 1995.
23. Kryszke MH and Vicart P. Regulation of the expression of the human vimentin gene: application to cellular immortalization. Pathol Biol (Paris) 46: 39-45, 1998.
24. Li Y, Jiang B, Ensign WY, Vogt PK, and Han J. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell Signal 12: 751-757, 2000.
25. Minden A, Lin A, McMahon M, Lange CC, Derijard B, Davis RJ, Johnson GL, and Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266: 1719-1723, 1994.
26. Ono K and Han J. The p38 signal transduction pathway: activation and function. Cell Signal 12: 1-13, 2000.
27. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, and Davis RJ. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255, 1996.
28. Vaittinen S, Lukka R, Sahlgren C, Hurme T, Rantanen J, Lendahl U, Eriksson JE, and Kalimo H. The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol 60: 588-597, 2001.
29. Volonte D, Galbiati F, Pestell RG, and Lisanti MP. Cellular Stress induces the tyrosine phosphorylation of caveolin-1 (Y14) via activation of p38 mitogen-activated protein (MAP) kinase and c-Src kinase: evidence for cell shape, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J Biol Chem 27: 27, 2000.
30. Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Wu W, Fahmy B, Olini GC, Davis JE, Pellegrino-Gensey JL, Wachter MP, and Siekierka JJ. RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. J Pharmacol Exp Ther 291: 680-687, 1999.
31. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, and Puri PL. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20: 3951-3964, 2000.
32. Yang SH, Galanis A, and Sharrocks AD. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol Cell Biol 19: 4028-4038, 1999.
33. Yee SP and Rigby PW. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev 7: 1277-1289, 1993.
34. Yeow K, Phillips B, Dani C, Cabane C, Amri EZ, and Derijard B. Inhibition of myogenesis enables adipogenic transdifferentiation in the C2C12 myogenic cell line. FEBS Lett 506: 157-162, 2001.
35. Zesehnigk M, Kozian D, Kuch C, Schmoll M, and Starzinski-Powitz A. Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J Cell Sci 108: 2973-2981, 1995.
36. Zetser A, Gredinger E, and Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 274: 5193-5200, 1999.
37. Zhao M, New L, Kravchenko W, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ, and Han J. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 19: 21-30, 1999.